Sinopharm Online, a pharmaceutical e-commerce platform owned by Chinese state-owned Sinopharm, announced on Friday that it has secured RMB300 million (US$44.57 million) in a series B round of financing led by healthcare-focused investment firm GTJA Investment Group.
Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech
Read 2 Articles for Free with a Basic Account
Gain limited and restricted access to China Money Network.Register Basic Account
Subscribe for an annual subscription!
Enjoy comprehensive and exclusive data you can't find elsewhere!More Info
Already have an account or paid subscription?